Client News

invIOs to Present Progress Across Oncology Pipeline During JP Morgan Week 2025

Medigene AG Submits Clinical Trial Application in Europe for MDG1015 for Multiple Solid Tumor Indications

Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England

Newron and EA Pharma (a Subsidiary of Eisai Co., Ltd.) Announce License Agreement for Evenamide in Japan and Other Asian Territories

New York Life Investments and its European Affiliate, Candriam, Announce Strategic Partnership with Andera Partners

Lindis Blood Care Announces Successful Financing for its Tumor-Cell-Removal Medical Device, CATUVAB®

Medigene AG Announces KRAS G12V as First Target for TCR-guided T Cell Engagers

MS Pharma Becomes Partner for the Commercialization of FYB202 / ustekinumab in the MENA Region

BioLizard Launches Bio|Verse® Navigator for Easy Exploration of Complex Biomedical Data

Galimedix Therapeutics Initiates Phase 1 Study with Oral Small Molecule, GAL-101, an Amyloid Beta (Aβ) Aggregation Modulator